Hot Deals:
5 star business 495.00 (-1.00 %) a v thomas 11,770.00 (-0.25 %) amol minechem 620.00 (1.64 %) anand i-power 20.00 anglo french 370.00 (-2.37 %) aricent 575.00 (0.88 %) arohan 181.00 (0.56 %) assam carbon 243.00 (-2.80 %) associated pigments limited 42.00 (-4.55 %) atlas copco 5,500.00 (1.85 %) auckland 130.00 (-3.70 %) axles 150.00 (11.11 %) b9 bira 772.00 (0.26 %) balmer lawrie van leer 300.00 bharat hotels 162.00 (1.25 %) bikaji foods 390.00 (1.04 %) boat 850.00 (-3.41 %) c & s electric 470.00 (-4.08 %) capgemini 11,000.00 (-2.22 %) care health 136.00 (-2.86 %) carrier aircon 260.00 (1.96 %) cial 180.00 (-1.64 %) csfbl 265.00 (-3.64 %) csk 160.00 (3.23 %) dalmia bharat refractories 81.00 (-4.71 %) east india pharmaceutical 39.00 (-2.50 %) eaton fluid 303.00 (1.00 %) electronica plastic 4,100.00 (-4.65 %) elgi ultra 400.00 elofic 1,909.00 (0.47 %) epiroc 1,224.00 (-2.08 %) esl steel 31.00 (-3.13 %) fincare 74.00 (1.37 %) fincare business services 43.00 fino paytech 145.00 (3.57 %) frick india 3,806.00 (0.16 %) gkn drive 1,051.00 (0.10 %) godavari biorefineries 71.00 (1.43 %) hdbfsl 600.00 (-2.44 %) hdfc ergo 363.80 hdfc securities 11,700.00 (1.74 %) hella india 190.00 (4.97 %) hero fincorp 714.00 (-1.24 %) hicks 2,100.00 (-2.55 %) hira ferro 121.00 (-3.20 %) honeywell electrical 3,555.00 (-1.25 %) icex 5.01 (0.20 %) incred financial 100.00 india carbon 1,060.00 (-3.64 %) india exposition mart 146.00 (0.69 %) indian potash limited 1,405.00 (0.36 %) indofil industries 700.00 (-1.41 %) infinite computer 700.00 inkel 12.95 (-0.38 %) ixigo 105.00 (-4.55 %) jana sfbl 75.00 kial 107.00 (-2.73 %) kurlon enterprise 640.00 (-3.03 %) kurlon limited 426.00 (-3.18 %) lava 123.00 (1.65 %) manipal hfsl 72.50 (0.69 %) manjushree technopack 1,010.00 (-3.81 %) martin and harris 1,980.00 (-1.98 %) merino 2,900.00 (-4.92 %) minosha 280.00 (-3.45 %) mitsubishi heavy industries 355.00 (1.43 %) mkcl 415.00 (1.22 %) mobikwik 450.00 (-4.26 %) mohan meakin 1,212.00 (1.00 %) mohfl 11.90 (-1.65 %) msei 1.00 (-4.76 %) msil 56.00 (3.70 %) nayara energy 150.00 (6.38 %) ncdex 275.00 ncl buildtek 175.00 (-5.41 %) ncl holdings 47.50 (1.06 %) nse 3,050.00 (-1.61 %) orbis financial 68.00 (1.49 %) oswal minerals 64.00 (-1.54 %) otis 3,800.00 (-2.56 %) oyo rooms 99.00 (-1.00 %) panasonic appliances 306.00 (0.33 %) panasonic avc 29.10 (0.34 %) paymate india 600.00 (-3.38 %) pharm easy 38.00 (-2.56 %) philips domestic 570.00 (3.64 %) philips india 1,100.00 (1.85 %) pnb metlife 70.00 proyuga adtech 25.00 ramaraju surgical 530.00 (0.57 %) reliance general insurance 340.00 resins plastics 414.00 (1.97 %) ring plus 370.00 (1.37 %) rrl 3,000.00 (3.45 %) sabmiller 350.00 (-2.78 %) satya micro 200.00 scottish assam 565.00 (-0.88 %) shriram life 251.00 (0.40 %) signify 1,050.00 (-6.75 %) smile microfin 56.00 (1.82 %) sri vishnu shankar 510.00 (-2.30 %) sterlite power 925.00 (2.78 %) studds 1,155.00 (0.43 %) t stanes 675.00 tata tech 5,250.00 (0.96 %) tmbl 530.00 (-1.85 %) trl krosaki 1,224.00 (-2.16 %) utkarsh coreinvest 127.00 (-2.31 %) vikram solar 55.50 (-0.89 %) xerox 243.00 (1.25 %)
×

claris life sciences Limited

250.00
+ 0.00 %
Scrip Name
CLARIS LIFE SCIENCE
ISIN No.
INE562G01018
PAN No.
AAACC6366Q
Face Value
10
No. of Outstanding Shares
54,567,765
Market Capitalization
1,364.19 Crore

CLARIS LIFESCIENCES LIMITED DELISTED SHARE


Founded on 19 July 1994, Claris Lifesciences Limited is a Public Limited Company it is involved in Human Healthcare Activities. It is registered at the registrar of companies in Ahmedabad.  Authorized equity capital of company is Rs. 1,205,100,030 and paid-up capital is Rs. 545,677,630.

Shares of Claris Lifesciences Limited were listed on the BSE.  The company's shares stopped trading on BSE on March 15, 2018, and it was delisted from the BSE on March 22, 2018. The exit offer price was Rs. 400 per share for public shareholders.


INCORPORATION DETAILS


CIN

U85110GJ1994PLC022543

Registration Date

19 July 1994

Company Name

Claris Lifesciences Limited

Email Address

secretarial@claris.in

GST Number

24AAACC6366Q1Z8

Category/Sub-category of the Company

Company Limited by Shares / Non-Government Company

Class of Company

Public

Listing status

Unlisted

Registration Number

22543

Statutory Auditors

Shah & Shah Associates, Ahmedabad

Address of the Registered office & contact details

Claris Corporate Headquarters, Nr. Parimal Railway Crossing, Ellisbridge, Ahmedabad - 380 006, India.

Company Secretary & Compliance Officer

Mr. Kirit H. Kanjaria.

Name, Address & contact details of the Registrar & Transfer Agent, if any

LINK INTIME INDIA PRIVATE LIMITED (Unit: Claris Lifesciences Limited) C-101, 247 Park, L B S Marg, Vikhroli (West), Mumbai - 400 083.


PARTICULAR OF SUBSIDIARY COMPANIES

S. No.

Name of the Company

Subsidiary

% of shares held


                                 Foreign Subsidiaries



1.

Claris Life Sciences Venezuela C.A.

Subsidiary

100%

2.

PT. Claris Life Sciences Indonesia

Subsidiary

100%


BOARD OF DIRECTORS

Mr. Surrinder Lal Kapur (Chairman  &  Non-Executive and Independent Director)

Mr. Arjun Handa (Vice-Chairman & Managing Director)

Mr. Aditya S. Handa (Non-Executive and Non-Independent Director)

Mr. Chandrasingh S. Purohit (Whole Time Director & CFO)

Mr. Shyamsunder  Sharma (Non-Executive and Non-Independent Director)

Dr. Anup P. Shah (Non-Executive and Independent Director)

 

SHAREHOLDING PATTERN

(As of 31-03-2021)


S. No.

Shareholder’s Name

No. of Shares

% of total Shares of the company

1

Promoter and Promoters Group

5,41,80,079

99.28%

2

Public

3,87,686

0.72%

 

Total

5,45,67,765

100%

 

PROFIT & LOSS STATEMENT OF CLARIS LIFESCIENCES LIMITED (Rs. In Lacs)

(As of 31-03-2018 to 31-03-2021)

PARTICULARS

2021

2020

2019

2018

INCOME





Other income

4.13

45.92

762.61

1,391.78

Total income

4.13

45.92

762.61

1,391.78

EXPENSES





Finance costs

0.04

0.22

-

-

Other expenses

31.39

145.49

1,246.98

1,793.80

Depreciation and amortization expense

-

-

-

10.31

Total expenses

31.43

145.71

1,246.98

1,804.11

Profit/(Loss) before tax

(27.30)

(99.79)

(484.37)

(412.33)

Tax expense / (benefit)



 

 

    Adjustment of tax relating to earlier years

-

(26.92)

-

449.77

    Deferred tax expense

-

428.37

264.70

(278.63)

    Current tax

-

         -

-

-

Total tax expense / (benefit)

-

401.45

264.70

171.14

Profit/(Loss) for the year from continuing operations

-

-

(749.07)

(583.47)

Profit before share in loss of Associate and tax from Discontinued operations

-

-

-

3,249.82

Tax Expense of Discontinued operations

-

-

-

1,110.18

Net Profit / (Loss) for the year from discontinued operations

-

-

-

2,139.64

Profit / (Loss) for the year

(27.30)

(501.24)

(749.07)

1,556.17

Other comprehensive income





Items that will be reclassified to profit and loss





       Exchange differences in translating the financial statements of a

       foreign operation

-

-

41.04

0.08

       Income tax effect on above

-

-

-

-

Total comprehensive income / (loss) for the year

(27.30)

(501.24)

(708.02)

1,556.25

Profit for the year from continuing operations attributable to :





       Owners of the company

-

-

(749.07)

(583.47)

       Non-controlling interest

-

-

-

-


-

-

(749.07)

(583.47)

Profit for the year from discontinued operations attributable to :





        Owners of the company

-

-

-

2,283.19

        Non-controlling interest

-

-

-

(143.55)


-

-

-

2,139.64

Profit / (Loss) for the year attributable to :





        Equity holders of the parent

(27.30)

(501.24)

-

-

        Owners of the company

-

-

(749.07)

1,699.72

        Non-controlling interest

-

-

-

(143.55)


(27.30)

(501.24

(749.07)

1,556.17

Other comprehensive income/(loss) for the year attributable to





        Equity holders of the parent

-

-

-

-

        Owners of the company

-

-

41.04

5.51

        Non-controlling interest

-

-

-

(5.43)


-

-

41.04

0.08

Total comprehensive income / (loss) for the year, net of tax





       Equity holders of the parent

(27.30)

(501.24)

-

-

       Owners of the company

-

-

(708.02)

1,705.23

       Non-controlling interest

-

-

-

(148.98)


(27.30)

(501.24)

(708.02)

1,556.25

Earnings per equity share of Rs.10 each





      Earnings per equity share (Basic)

(0.05)

(0.92)

-

-

      Earnings per equity share (Diluted)

(0.05)

(0.92)

-

-

      Continuing Operations

-

-

(1.37)

(1.07)

      Discontinued Operations

-

-

-

4.18

Continuing & Discontinued Operations

-

-

(1.37)

3.11

 

BALANCE SHEET OF CLARIS LIFESCIENCES LIMITED (Rs. In Lacs)

(As of 31-03-2018 to 31-03-2021)


PARTICULARS

2021

2020

2019

2018

ASSETS





Non-current assets





Deferred tax assets (net)

527.85

527.85

956.21

1,220.91

Income tax assets (net)

104.89

104.78

-

-

Non-current tax assets (net)

-

-

634.64

626.74

Property, plant, and equipment

-

-

-

-

Capital work-in-progress

-

-

-

-

Intangible assets

-

-

-

-

Financial assets





     Investments

-

-

-

-

TOTAL

632.74

632.63

1,590.85

1,847.65

Current assets





Financial assets





      Trade receivables

-

-

62.68

58.10

      Cash and cash equivalents

11.63

18.11

27.43

6.88

      Other bank balances

36.02

38.87

38.38

31.60

      Other financial assets

258.76

269.69

341.95

131.62

Other current assets

39.44

39.18

111.98

326.89

TOTAL CURRENT ASSETS

345.85

365.85

582.42

555.09

TOTAL ASSETS

978.59

998.48

2,173.27

2,402.74

EQUITY AND LIABILITIES EQUITY





Equity share capital

5,456.78

5,456.78

5,456.78

5,456.78

Other equity

(6,622.90)

(6,595.60)

(6,094.36)

(5,386.34)

TOTAL EQUITY

(1,166.12)

(1,138.82)

(637.58)

70.44

LIABILITIES





Current liabilities





Financial liabilities





      Borrowings

2,101.30

2,097.30

-

-

      Trade payables





        Total outstanding dues of micro-enterprises

        and small enterprises

0.54

-

-

-

       Total outstanding dues of creditors other than

       micro-enterprises and small enterprises

34.86

25.04

24.56

192.04

    Other financial liabilities

4.88

12.43

2,783.91

2,003.68

Other current liabilities

3.13

2.53

2.38

136.58

TOTAL CURRENT LIABILITIES

2,144.71

2,137.30

2,810.85

2,332.30

TOTAL EQUITY AND LIABILITIES

978.59

998.48

2,173.27

2,402.74

 

DIVIDEND AND RETAINED EARNINGS

(As of 31-03-2018 to 31-03-2019)

Particulars

2021

2020

2019

2018

Dividend

Nil

Nil

Nil

Nil

Retained Earnings (In Rs. Lakhs)

(6,622.90)

(6,595.60)

(6,181.03)

(5,431.96)

 

PERFORMANCE OF THE COMPANY

Income decreased from Rs. 45.92 Lacs in FY 2020 to Rs. 4.13 Lacs in FY 2021, showing a decline of 91.01% as compared to the previous financial year.


Finance Cost has decreased from Rs. 0.22 Lacs in FY 2020 to Rs.  0.04 Lacs in FY 2021.


In FY 2021, Company’s Net Loss stood at Rs. 27.30 Lacs,  as against Rs. 501.24 Lakh loss of FY 2020.


The Current Ratio of the company as of 31st March 2021 was 0.16%.

 

The debt to equity ratio of the company as of 31st March 2021 was 0.83%.


In the Financial Year 2020-21, the company has not paid dividends.


 

Powered by Froala Editor

Annual Reports

2020-21

Download

2019-20

Download

2018-19

Download

2017-18

Download

2016-17

Download

2015-16

Download

2014-15

Download

2012-13

Download

Corporate Actions

Exit offer Claris Life Science dated 16-02-2018

Download

Recent News

Wealth Wisdom - WWIPL
Support Megha Support Neha Support Pallavi